11/14/2025
This article lays out how have dominated the industry and has some interesting ideas about making the PBM industry a little more competitive.
When control over prescription drug access rests with only a few players, the result is not just market imbalance — it is higher plan costs, increased financial pressures, and ultimately reduced affordability for patients.